Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Prepaid Assets (2016 - 2025)

Aptevo Therapeutics' Prepaid Assets history spans 11 years, with the latest figure at $1.5 million for Q3 2025.

  • For Q3 2025, Prepaid Assets fell 7.58% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, down 7.58%, while the annual FY2024 figure was $256000.0, 82.62% down from the prior year.
  • Prepaid Assets for Q3 2025 was $1.5 million at Aptevo Therapeutics, down from $1.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.4 million in Q3 2021 and bottomed at $66000.0 in Q2 2021.
  • The 5-year median for Prepaid Assets is $1.3 million (2025), against an average of $1.1 million.
  • The largest YoY upside for Prepaid Assets was 1270.68% in 2021 against a maximum downside of 93.22% in 2021.
  • A 5-year view of Prepaid Assets shows it stood at $1.8 million in 2021, then dropped by 13.82% to $1.6 million in 2022, then fell by 6.24% to $1.5 million in 2023, then crashed by 82.62% to $256000.0 in 2024, then surged by 490.23% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for APVO's Prepaid Assets are $1.5 million (Q3 2025), $1.6 million (Q2 2025), and $1.3 million (Q1 2025).